Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 157
 
About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Advertise Login 
     
CASE REPORT
Year : 2020  |  Volume : 9  |  Issue : 4  |  Page : 289-291

Use of high-dose octreotide in the treatment of congenital chylothorax


Department of Pediatrics, Unaizah College of Medicine and Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia

Correspondence Address:
Dr. Mohammad Abdulaziz Alhasoon
Department of Pediatrics, Unaizah College of Medicine and Medical Sciences, Qassim University, Buraydah
Kingdom of Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jcn.JCN_38_20

Rights and Permissions

The report provides a critical examination of the use of octreotide at a dosage of 20 μg/kg/h in the treatment of congenital chylothorax. The case analysis recounts a recent application of high-dosage octreotide in the treatment of a neonatal patient who failed to respond to a lower dosage of octreotide. In this case, the patient responded effectively to octreotide at 20 μg/kg/h and was subsequently discharged without any side effects. This case is compared with similar cases published in recent literature to advance the clinical analysis of a potential application of high-dose octreotide in the treatment of congenital chylothorax when lower dosages fail to produce results.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
  Search Pubmed for
  Search in Google Scholar for
Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed49    
    Printed0    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal